Contract Research in the Indian Pharmaceutical Industry

BCase Studies | Case Study in Business, Management, Business Reports, Company Reports, Industry Reports, Operations, Strategy, Marketing, Finance, Corporate Governance, Economics, Project Management, Insurence, Free Management Case Study,

ICMR HOME | Business Reports

Case Details:

Report Code : BREP030
Report Length : 18 Pages
Period : 2000-05
Organization : Quintiles Spectral (India) Limited, Syngene International Private Limited, Clinigene International Private Limited, Vimta Labs
Pub Date : 2006
Teaching Note : Not Available
Countries : India
Industry : Pharma/Biotechnology

To download Contract Research in the Indian Pharmaceutical Industry case study (Report Code: BREP030) click on the button below, and select the report from the list of available report:

Buy With PayPal

Price:

For delivery in electronic format: Rs. 400 ;
For delivery through courier (within India): Rs. 400 + Rs. 25 for Shipping & Handling Charges

» Business Reports
» Business Updates
» Case Studies Collection
» Short Case Studies
» View Detailed Pricing Info
» How to Order this Report

Custom Search

Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.

Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

<< Previous

Introduction

The success of business process outsourcing (BPO) related services in India has prompted a few companies to start off shoring high-end knowledge-based activities as well. These activities include investment research, clinical research, drug discovery, patent filing, and legal and insurance claims.

The Confederation of Indian Industries (CII) , in a paper titled 'India in the New Knowledge Economy'has projected the growth of the knowledge process outsourcing (KPO) industry at a cumulative annual rate of 46%, reaching US$ 17 billion mark with India holding a 70% market share globally in this area, by 2010.

Business Reports | Case Study in Management, Operations, Strategies, Business Reports, Case Studies

The paper expects that KPO will take place in the pharmaceutical, biotechnology, information & communication technology, legal, intellectual property research, automobile and aerospace industries. The Indian pharma industry was worth about US$ 8 billion in 2004 (Refer Exhibit I for Indian Pharmaceutical Industry Fact Sheet in 2004).

The industry grew at an average of 9% per annum between 2000 and 2005. There were about 20,000 players in the industry (about 300 in the organized sector) in 2004. About one-third of the industry's revenues come from the top ten companies in the industry. Pharma companies in India conduct research and development (R&D), manufacturing, marketing and distribution of drugs. R&D in the pharma sector in India, in comparison to advanced countries such as the US and the UK, is still at a nascent stage. Global pharma companies can benefit immensely from KPO in R&D, owing to India's large pool of trained scientists, and the large doctor and patient population as well...

Contents >>